Management of metabolic complications of therapyCURRIER, Judith.AIDS (London). 2002, Vol 16, pp S171-S176, issn 0269-9370, SUP4Article

Cardiovascular risk associated with HIV therapyCURRIER, Judith S.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, pp S16-S23, issn 1525-4135, SUP1Article

Simpler, safer HAART: moving toward a new standard of careCURRIER, Judith S.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, issn 1525-4135, 27 p., SUP1Serial Issue

Once-daily HAART: Toward a new treatment paradigmFRANK, Ian.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, pp S10-S15, issn 1525-4135, SUP1Article

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study : a multi-cohort collaboration. CommentarySTEIN, James H; CURRIER, Judith S.Lancet (British edition). 2008, Vol 371, Num 9622, issn 0140-6736, 1391-1392, 1417-1426 [12 p.]Article

Cardiovascular risk factors and antiretroviral therapyKURITZKES, Daniel R; CURRIER, Judith.The New England journal of medicine. 2003, Vol 348, Num 8, pp 679-680, issn 0028-4793, 2 p.Article

Dyslipidemia and Cardiovascular Risk in Human Immunodeficiency Virus InfectionKELESIDIS, Theodoros; CURRIER, Judith S.Endocrinology and metabolism clinics of North America (Print). 2014, Vol 43, Num 3, issn 0889-8529, 665-684, vii [21 p.]Article

Postexposure Prophylaxis for HIV InfectionLANDOVITZ, Raphael J; CURRIER, Judith S.The New England journal of medicine. 2009, Vol 361, Num 18, pp 1768-1775, issn 0028-4793, 8 p.Article

Sorting through confusing messages: The art of HAARTPOWDERLY, William G.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, pp S3-S9, issn 1525-4135, SUP1Article

Metabolic disease in HIV infectionLAKE, Jordan E; CURRIER, Judith S.Lancet. Infectious diseases (print). 2013, Vol 13, Num 11, pp 964-975, issn 1473-3099, 12 p.Article

A High Incidence of Lactic Acidosis and Symptomatic Hyperlactatemia in Women Receiving Highly Active Antiretroviral Therapy in Soweto, South Africa. CommentaryBOLHAAR, M. G; KARSTAEDT, A. S; CURRIER, Judith S et al.Clinical infectious diseases. 2007, Vol 45, Num 2, pp 254-262, issn 1058-4838, 9 p.Article

Availability of HIV Postexposure Prophylaxis Services in Los Angeles CountyLANDOVITZ, Raphael J; COMBS, Kory B; CURRIER, Judith S et al.Clinical infectious diseases. 2009, Vol 48, Num 11, pp 1624-1627, issn 1058-4838, 4 p.Article

Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South AfricaHOFFMAN, Risa M; BLACK, Vivian; TECHNAU, Karl et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 1, pp 35-41, issn 1525-4135, 7 p.Article

Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients : the ASCENT (CCR102881) studyCURRIER, Judith; LAZZARIN, Adriano; SLOAN, Louis et al.Antiviral therapy (London). 2008, Vol 13, Num 2, pp 297-306, issn 1359-6535, 10 p.Article

Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4⁺ T-cell countGRINSZTEJN, Beatriz; SMEATON, Laura; BARNETT, Ronald et al.Antiviral therapy (London). 2011, Vol 16, Num 7, pp 1057-1062, issn 1359-6535, 6 p.Article

Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutinHAMZEH, Fayez M; BENSON, Constance; GERBER, John et al.Clinical pharmacology and therapeutics. 2003, Vol 73, Num 3, pp 159-169, issn 0009-9236, 11 p.Article

HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexualWOHL, Amy Rock; JOHNSON, Denise F; LU, Sharon et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 3, pp 354-360, issn 1525-4135, 7 p.Article

First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialCIARANELLO, Andrea L; LOCKMAN, Shahin; MCINTYRE, James et al.AIDS (London). 2011, Vol 25, Num 4, pp 479-492, issn 0269-9370, 14 p.Article

Regional Adipose Tissue and Lipid and Lipoprotein Levels in HIV-Infected WomenCURRIER, Judith; SCHERZER, Rebecca; BACCHETTI, Peter et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 1, pp 35-43, issn 1525-4135, 9 p.Article

High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centersWOHL, Amy Rock; JOHNSON, Denise; JORDAN, Wilbert et al.Journal of acquired immune deficiency syndromes (1999). 2000, Vol 24, Num 4, pp 386-392, issn 1525-4135Article

Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapineMWAFONGO, Albert; NKANAUNENA, Kondwani; HOSSEINIPOUR, Mina et al.AIDS (London). 2014, Vol 28, Num 8, pp 1135-1142, issn 0269-9370, 8 p.Article

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patientsMCCUTCHAN, J. Allen; WU, Julia W; WILLIAMS, Paige L et al.AIDS (London). 2007, Vol 21, Num 9, pp 1109-1117, issn 0269-9370, 9 p.Article

HIV health care services for Mexican migrantsSOLORIO, M. Rosa; CURRIER, Judith; CUNNINGHAM, William et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, pp S240-S251, issn 1525-4135, SUP4Article

Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudineHAAS, David W; ARATHOON, Eduardo; BENETUCCI, Jorge et al.AIDS (London). 2000, Vol 14, Num 13, pp 1973-1978, issn 0269-9370Article

Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 InfectionKELESIDIS, Theodoros; KENDALL, Michelle A; YANG, Otto O et al.The Journal of infectious diseases. 2012, Vol 206, Num 10, pp 1558-1567, issn 0022-1899, 10 p.Article